We report two occupationally acquired cases of American cutaneous leishmaniasis (ACL): one accidental laboratory autoinoculation by contaminated needlestick while handling an ACL lesion sample, and one acquired during field studies on bird biology. Polymerase chain reaction (PCR) assays of patient lesions were positive for Leishmania, subgenus Viannia. One isolate was obtained by culture (from patient 2 biopsy samples) and characterized as Leishmania (Viannia) naiffi through an indirect immunofluorescence assay (IFA) with species-specific monoclonal antibodies (mAbs) and by multilocus enzyme electrophoresis (MLEE). Patients were successfully treated with N-methyl-glucamine. These two cases highlight the potential risks of laboratory and field work and the need to comply with strict biosafety procedures in daily routines. The swab collection method, coupled with PCR detection, has greatly improved ACL laboratory diagnosis. 1. Introduction Health professionals such as physicians, nurses, and laboratory workers and researchers and students in the biological sciences are at risk of a number of occupational infections [1]. Accidents involving contaminated “sharps” are, in general, extremely dangerous due to the high likelihood of infectious agent transmission. Exposure to blood-borne pathogens represents an especially serious risk. Needlestick and sharps contamination accidents involving at least 20 different pathogens, most commonly hepatitis B and C or human immunodeficiency virus (HIV), have been reported [1]. Some occupational accidents with Leishmania spp. related to percutaneous injuries, contaminated animal/culture handling, or lesion sample collection have also been reported [2]. ACL diagnosis is based on clinical, epidemiological, and laboratorial criteria. However, clinical diagnosis is often difficult due to the varied presentation of the disease, and the epidemiological criteria may go unnoticed because clinicians are not aware of the existence or nature of the disease [3, 4]. Laboratory diagnosis includes the direct identification of amastigotes through direct examinations of stained smears from imprints or histological sections, isolation of promastigotes by culture, and immune-based methods (e.g., ELISA, Western blot, indirect immunofluorescence (IFAT), and delayed hypersensitivity or Montenegro intradermoreaction (MIDR), [5, 6]. Laboratory procedures may be hindered by the scarcity of amastigotes in the wounds, especially in late stages of the disease and secondary infections, or by the low sensitivity and cross reactivity of serological
References
[1]
C. H. Collins and D. A. Kennedy, “Microbiological hazards of occupational needlestick and “sharps” injuries,” Journal of Applied Bacteriology, vol. 62, no. 5, pp. 385–402, 1987.
[2]
B. L. Herwaldt, “Laboratory-acquired parasitic infections from accidental exposures,” Clinical Microbiology Reviews, vol. 14, no. 4, pp. 659–688, 2001.
[3]
G. Grimaldi and R. B. Tesh, “Leishmaniases of the new world: current concepts and implications for future research,” Clinical Microbiology Reviews, vol. 6, no. 3, pp. 230–250, 1993.
[4]
K. Kar, “Serodiagnosis of leishmaniasis,” Critical Reviews in Microbiology, vol. 21, no. 2, pp. 123–152, 1995.
[5]
J. J. Shaw and R. Lainson, “Leishmaniasis in Brazil—X. Some observations on intradermal reactions to different trypanosomatid antigens of patients suffering from cutaneous and mucocutaneous leishmaniasis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 69, no. 3, pp. 323–335, 1975.
[6]
M. E. F. Brito, M. G. Mendon?a, Y. M. Gomes, M. L. Jardim, and F. G. C. Abath, “Identification of potentially diagnostic Leishmania braziliensis antigens in human cutaneous leishmaniasis by immunoblot analysis,” Clinical and Diagnostic Laboratory Immunology, vol. 7, no. 2, pp. 318–321, 2000.
[7]
S. F. Brenière, J. Telleria, M. F. Bosseno et al., “Polymerase chain reaction-based identification of New World Leishmania species complexes by specific kDNA probes,” Acta Tropica, vol. 73, no. 3, pp. 283–293, 1999.
[8]
E. H. Gomes Rodrigues, M. E. Felinto De Brito, M. G. Mendon?a et al., “Evaluation of PCR for diagnosis of American cutaneous leishmaniasis in an area of endemicity in Northeastern Brazil,” Journal of Clinical Microbiology, vol. 40, no. 10, pp. 3572–3576, 2002.
[9]
T. Mimori, T. Matsumoto, M. H. Calvopi?a et al., “Usefulness of sampling with cotton swab for PCR-diagnosis of cutaneous leishmaniasis in the New World,” Acta Tropica, vol. 81, no. 3, pp. 197–202, 2002.
[10]
M. H. L. De Bruijn and D. C. Barker, “Diagnosis of New World leishmaniasis: specific detection of species of the Leishmania braziliensis complex by amplification of kinetoplast DNA,” Acta Tropica, vol. 52, no. 1, pp. 45–58, 1992.
[11]
J. J. Shaw, E. A. Y. Ishikawa, and R. Lainson, “A rapid and sensitive method for the identification of Leishmania with monoclonal antibodies using fluorescein-labelled avidin,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 83, no. 6, pp. 783–784, 1989.
[12]
E. Cupolillo, G. Grimaldi Jr., and H. Momen, “Discrimination of Leishmania isolates using a limited set of enzymatic loci,” Annals of Tropical Medicine and Parasitology, vol. 89, no. 1, pp. 17–23, 1995.
[13]
BRASIL, Secretaria de Vigilancia em Saúde. Departamento de Vigilancia Epidemiológica. Manual de Vigilancia da Leishmaniose Tegumentar Americana. 2nd ed. Brasília: Ed. do Ministério da Saúde, 2007.
[14]
J. Shaw, “The leishmaniases—survival and expansion in a changing world. A mini-review,” Memorias do Instituto Oswaldo Cruz, vol. 102, no. 5, pp. 541–546, 2007.
[15]
M. E. F. Brito, M. S. Andrade, M. G. Mendon?a et al., “Species diversity of Leishmania (Viannia) parasites circulating in an endemic area for cutaneous leishmaniasis located in the Atlantic rainforest region of northeastern Brazil,” Tropical Medicine and International Health, vol. 14, no. 10, pp. 1278–1286, 2009.
[16]
R. Lainson, J. J. Shaw, F. T. Silveira, R. R. Braga, and E. A. Ishikawa, “Cutaneous leishmaniasis of man due to Leishmania (Viannia) naiffi Lainson and Shaw, 1989,” Annales de Parasitologie Humaine et Comparee, vol. 65, no. 5-6, pp. 282–284, 1990.
[17]
R. Aragort de Rossell, R. De Jesus de Duran, O. Rossell, and A. M. Rodriguez, “Is leishmaniasis ever cured?” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 86, no. 3, pp. 251–253, 1992.
[18]
T. Aebischer, “Recurrent cutaneous leishmaniasis: a role for persistent parasites?” Parasitology Today, vol. 10, no. 1, pp. 25–28, 1994.
[19]
J. L. Ramírez and P. Guevara, “Persistent infections by Leishmania (Viannia) braziliensis,” Memorias do Instituto Oswaldo Cruz, vol. 92, no. 3, pp. 333–338, 1997.
[20]
A. Schubach, M. C. A. Marzochi, T. Cuzzi-Maya et al., “Cutaneous scars in American tegumentary leishmaniasis patients: a site of Leishmania (Viannia) braziliensis persistence and viability eleven years after antimonial therapy and clinical cure,” American Journal of Tropical Medicine and Hygiene, vol. 58, no. 6, pp. 824–827, 1998.
[21]
M. G. Mendon?a, A. E. F. De Brito, E. H. G. Rodrigues, V. Bandeira, M. L. Jardim, and F. G. C. Abath, “Persistence of Leishmania parasites in scars after clinical cure of american cutaneous leishmaniasis: is there a sterile cure?” Journal of Infectious Diseases, vol. 189, no. 6, pp. 1018–1023, 2004.